Results 191 to 200 of about 65,900 (283)

Safety, Efficacy and Treatment Patterns of rIX‐FP in Previously Untreated Paediatric Haemophilia B Patients: A Retrospective Chart Review in Japan

Haemophilia, EarlyView.
Abstract Background Limited real‐world data exist on recombinant fusion protein‐linking coagulation factor IX (FIX) with albumin (rIX‐FP) in paediatric previously untreated patients (PUPs) with haemophilia B, particularly in infants. Aims To evaluate the treatment patterns, safety and efficacy of rIX‐FP in paediatric PUPs in Japan.
Keiji Nogami, Chiai Nagae, Masatoshi Yono, Naoki Terasaka   +3 more
wiley   +1 more source

Severe anaphylaxis following off-label rectal use of injectable diazepam in a febrile seizure: a case report and clinical implications. [PDF]

Int J Emerg Med
Nguyen NX, Pham NT, Le HTT, Tran QV, Tran HNT, Vo TKT, Dang CTN.   +6 more
europepmc   +1 more source

Anaphylaxis Management in Paediatric Patients Undergoing Milk Oral Immunotherapy [PDF]

Dimitry Buyansky, Roy Khalaf, Sofianne Gabrielli, Julia Upton, Eyal Grunebaum, Edmond S. Chan, Ingrid Baerg, Liane Beaudette, Danbing Ke, Bruce Mazer, Christine McCusker, Duncan Lejtenyi, Moshe Ben‐Shoshan   +12 more
openalex   +1 more source

Insights Into Hereditary Alpha‐Tryptasemia From a Genome‐Wide Association Study in Hymenoptera Venom Anaphylaxis

Clinical &Experimental Allergy, EarlyView.
Teresa Blanco‐Ramos, Raquel Cruz, Irene Fernández‐Franco, Mª Ángeles Vargas, Ángel Carracedo, Arturo González‐Quintela, Carmen Vidal   +6 more
wiley   +1 more source

New Hydrophilic Helixone Dialyzers as an Alternative for Hemodialysis Patients With Membrane Hypersensitivity Reactions: A Retrospective Single‐Cohort Study

Hemodialysis International, EarlyView.
ABSTRACT Background Synthetic dialysis membranes, particularly those composed of polysulfone blended with polyvinylpyrrolidone, are commonly used in hemodialysis due to their efficiency. However, hypersensitivity reactions—often atypical and not fitting traditional type A and B classifications—have increasingly been reported.
Víctor Joaquín Escudero‐Saiz, Elena Cuadrado‐Payán, Eugenia Castellote, Roxana Buri, Higini Cao, Silvia Collado, Lida Maria Rodas, Néstor Fontseré, José Jesús Broseta, Francisco Maduell   +9 more
wiley   +1 more source

Insights Into Complex Murine Models of Allergy and Anaphylaxis: The Central Role of IgE and Mast Cells in Advancing Human Therapies. [PDF]

Eur J Immunol
Nagata Y, Suzuki R.
europepmc   +1 more source

First successful protocol for desensitization to eptinezumab

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Background Eptinezumab is an anti‐calcitonin gene‐related peptide monoclonal antibody used for migraine prevention. During clinical trials, hypersensitivity to eptinezumab was described without a clear underlying mechanism. To determine if the reaction was immunoglobulin E–mediated, the team of Nice University Hospital (Nice, France) performed
Benoit Gerard, Hubert Praudel, Michel Lanteri‐Minet, Elise Van Obberghen, Fanny Rocher‐Moreau, Johanna Rousset, Ulysse Jacquier, Sylvie Leroy, Margot Delin   +8 more
wiley   +1 more source

A reference centre experience in central Anatolia in terms of causes, severity and treatment of childhood anaphylaxis. [PDF]

North Clin Istanb
Guzel T, Ermistekin H, Goktas S, Tahan F.   +3 more
europepmc   +1 more source

Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin, Marie Tauber, Robert Sidbury, Jonathan I. Silverberg, Kim A. Papp, Diamant Thaçi, Marjolein S. De Bruin‐Weller, Adam Reich, Ketty Peris, Kirk Barber, Ryszard Galus, Andrzej Kaszuba, Matthew Zirwas, Walter K. Nahm, Gretel Trullenque, Laura Maintz, Sady Alpizar, Sang Wook Son, Vivian Laquer, Linda Stein Gold, Soo Yeon Cheong, Anna Ryzhkova, Agnes Drahos, Liliana Ulianov, Christophe Piketty   +24 more
wiley   +1 more source

Severe anaphylactic reaction to contrast agent: teams are well prepared but should simulate the situations regularly. [PDF]

Br J Radiol
Pape KC, Meissnitzer M, Strüby Z, Sartoretti T, Harder D, Matoori S, Froehlich JM, Schindera S, Laures S, Hälg C, Hergan K, Hecht S, Konrad C, Hausmann O, Elfgen J, Najafi A, Bech-Hohenberger R, Koh DM, Gutzeit A.   +18 more
europepmc   +1 more source